BMJ 2002;324:1417-1419 ( 15 June )

Papers

Quality of life measurement: bibliographic study of patient assessed health outcome measures

Andrew Garratt, research officer aLouise Schmidt, research officer aAnne Mackintosh, database manager aRay Fitzpatrick, professor b

a National Centre for Health Outcomes Development, Unit of Health-Care Epidemiology, Institute of Health Sciences, University of Oxford, Oxford OX3 7LF, b Department of Public Health, Institute of Health Sciences, University of Oxford, Oxford OX3 7LF

Correspondence to: A Garratt andrew.garratt{at}uhce.ox.ac.uk


    Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References

Objectives: To assess the growth of quality of life measures and to examine the availability of measures across specialties.
Design: Systematic searches of electronic databases to identify developmental and evaluative work relating to health outcome measures assessed by patients.
Main outcome measures: Types of measures: disease or population specific, dimension specific, generic, individualised, and utility. Specialties in which measures have been developed and evaluated.
Results: 3921 reports that described the development and evaluation of patient assessed measures met the inclusion criteria. Of those that were classifiable, 1819 (46%) were disease or population specific, 865 (22%) were generic, 690 (18%) were dimension specific, 409 (10%) were utility, and 62 (1%) were individualised measures. During 1990-9 the number of new reports of development and evaluation rose from 144 to 650 per year. Reports of disease specific measures rose exponentially. Over 30% of evaluations were in cancer, rheumatology and musculoskeletal disorders, and older people's health. The generic measures---SF-36, sickness impact profile, and Nottingham health profile---accounted for 612 (16%) reports.
Conclusions: In some specialties there are numerous measures of quality of life and little standardisation. Primary research through the concurrent evaluation of measures and secondary research through structured reviews of measures are prerequisites for standardisation. Recommendations for the selection of patient assessed measures of health outcome are needed.

What is already known on this topic
Quality of life measures are increasingly used for measuring health outcomes in evaluative research

There is little standardisation in the use of such measures within clinical trials

What this study adds
There has been exponential growth in reports relating to the development and evaluation of quality of life measures

The number of reports varies considerably according to the health problem




    Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References

Clinical trials and similar forms of evaluative study should incorporate the patient's perspective of outcome.1 For complete assessment of the benefits of an intervention it is essential to provide evidence of the impact on the patient in terms of health status and health related quality of life. These terms refer to experiences of illness such as pain, fatigue, and disability and also broader aspects of the individual's physical, emotional, and social wellbeing. 2 3 Unlike conventional medical indicators, these broader impacts of illness and treatment need, wherever possible, to be assessed and reported by the patient.

Several reviews have criticised researchers for their failure to use appropriate measures of health related quality of life in evaluations purporting to address the impact of interventions by assessing outcomes of concern to patients.3-7 We undertook an extensive review to describe the extent to which patient assessed outcome measures have been developed and applied and examined whether such instruments are available for all aspects of clinical research.


    Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References

Search strategy---We retrieved reports relating to the development and evaluation of patient assessed measures. We based our search terms on terminology applicable to the development and evaluation of patient assessed health outcomes and terminology used in structured reviews. 3 8 We searched the following from their inception to 2000: AMED, Biological Abstracts, British Nursing Index, Cinahl, Econlit, Embase, Medline, PAIS International, PsycInfo, Royal College of Nursing database, Sigle, and Sociological Abstracts.

Assessment of reports---The inclusion criteria comprised the development and testing of patient assessed measures including aspects of health status and quality of life, summary items, and symptoms. We excluded reports that related solely to the use of measures. We assessed the reports for the different types of measure (box) and specialties using a classification based on that used in a review of quality of life measures within randomised clinical trials, supplementing where necessary.2

Types of measure

Dimension specific measures focus on particular aspects of health such as psychological wellbeing and usually produce a single score---for example, Beck depression inventory9

Disease or population specific measures include aspects of health that are relevant to particular health problems and may measure several health domains---for example, asthma quality of life questionnaire10

Generic measures can be used across different patient populations; they usually measure several health domains---for example, SF-3611

Individualised measures allow respondents to include and weight the importance of aspects of their own life; they usually sum to produce a single score---for example, patient generated index12

Utility measures have been developed for economic evaluation, incorporate preferences for health states, and produce a single index---for example, EuroQol EQ-5D13




    Results
Top
Abstract
Introduction
Methods
Results
Discussion
References

Search strategy
After we removed duplicates the initial download from the electronic databases produced 23 042 records. Of these, 3921 (17%) met the inclusion criteria and reported on the development and testing of patient assessed measures of health outcome. The 3921 reports cited 1275 identifiable measures. The number of reports increased from 144 new records in 1990 to 650 in 1999 (figure). At the time of our search the databases were incomplete for 2000. 



View larger version (23K):
[in this window]
[in a new window]
 
Number of reports for four main types of measure by year

There was considerable overlap between the types of measure because a large number report the concurrent validation of measures. Most (1819) reported the development and evaluation of measures specific for a disease or population; 865 reported generic measures; 690 reported dimension specific measures; 409 reported utility measures; and 62 reported individualised measures (see bmj.com).

The largest number of evaluations were for rheumatology and musculoskeletal medicine, cancer, and older people; these three accounted for 31% of the 3921 reports. Mental health, neurological diseases, paediatrics-child health, and respiratory diseases were the only other specialties that accounted for more than 5% of records each. There were also a large number of reports (6%) for generic and utility measures that have been evaluated within general populations (for more detail see bmj.com).

The arthritis impact measurement scales,14 health assessment questionnaire,15 and European Organisation for Research into the Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30)16 were the three disease specific measures reported most frequently (table). However it was the generic measures, including the SF-36,11 sickness impact profile,17 and Nottingham health profile18 that had undergone the largest number of evaluations. These three measures accounted for 16% of the total number of reports; they have been evaluated across numerous patient populations and have been translated into several languages. Population norms are also widely available for these measures. Of the utility measures, the EuroQol13 and health utilities index19 have undergone the largest number of evaluations.


                              
View this table:
[in this window]
[in a new window]
 

Most widely evaluated measures within 3921 reports




    Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References

The application of patient assessed measures of health outcome has become increasingly important to evaluation of health care.1 We have shown considerable growth in the production of measures to support this trend. Growth has not been consistent across specialties or health problems and has been concentrated around the development of measures specific for diseases or populations.

Selection of measures
The different types of measure are all potentially useful for evaluating health outcomes from the perspective of the individual patient, and there are now multiple measures available within these individual categories. Those wishing to select a measure for a specific application face quite a daunting task. Although there is some evidence for the standardisation of generic measures with a few measures achieving widespread application, this is not the case for disease specific measures. For many patient populations there are several specific measures. It is perhaps not surprising that there is evidence of a lack of consistency in the selection of measures for clinical trials which hinders comparisons between studies.2 In a study of 67 clinical trials, 48 were found to use 62 different existing measures and 13 reported new measures.2

The selection of measures can be informed through primary research that compares measures against recommended criteria,3 recommendations based on expert consensus, and structured reviews that assess the evidence for different measures. The concurrent evaluation of measures within primary research typically involves the comparative evaluation of reliability, validity, and responsiveness. Recommendations have been produced for the use of patient assessed measures in rheumatoid arthritis and back pain. 20 21 Our search strategy identified 314 reviews of instruments. The quality of the reviews was variable with just 47 using the words comprehensive, structured, or systematic within the title or abstract. Most reviews compared measures for reliability, validity, and responsiveness to change. However several other important considerations relating to the selection of patient assessed measures have been described, 3 22 the most pertinent being the relevance of the content of a measure to the proposed application.

Conclusions
The huge growth in the number of patient assessed measures of health outcome has obvious benefits in terms of the availability of measures for specific populations. However, potential users require guidance particularly when faced with multiple measures. Structured reviews together with recommendations based on patient and professional consensus are required for the effective application of measures. Concurrent evaluation can also help to determine the most suitable measure for a particular application. Finally, researchers should undertake comprehensive literature searches to ascertain whether a suitable measure is available before they decide to develop a new one.



    Acknowledgments

We thank Elizabeth Oram and Monique Raats, who helped with data management and literature searches.

Contributors: See bmj.com

    Footnotes

Funding: AG, AM, and LS are funded by the Department of Health as part of its funding of the National Centre for Health Outcomes Development. The views expressed in this paper are those of the authors and not necessarily those of the Department of Health.

Competing interests: None declared.

The full version of this article appears on bmj.com


    References
Top
Abstract
Introduction
Methods
Results
Discussion
References

1. Fitzpatrick R, Davey C, Buxton M, Jones DR. Criteria for assessing patient based outcome measures for use in clinical trials. In: Stevens A, Abrams K, Brazier J, Fitzpatrick R, Lilford R, eds. The advanced handbook of methods in evidence based healthcare. London: Sage, 2001:181-194.
2. Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 1998; 317: 1191-1194[Abstract/Free Full Text].
3. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998; 2: 1-74.
4. Hayes JA, Black NA, Jenkinson C, Young JD, Rowan KM, Daly K, et al. Outcome measures for adult critical care: a systematic review. Health Technol Assess 2000; 4: 1-111[Medline].
5. Baker GA, Hesdon B, Marson AG. Quality of life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 2000; 41: 1357-1363[CrossRef][Web of Science][Medline].
6. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001; 108: 74-86[CrossRef].
7. Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. Stroke 2000; 31: 1429-1438[Abstract/Free Full Text].
8. Garratt AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review. Diabet Med 2002; 19: 1-11.
9. Beck A, Ward C, Medelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
10. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832-838[Web of Science][Medline].
11. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care 1992; 30: 473-483[Web of Science][Medline].
12. Ruta DA, Garratt AM, Russell IT. Patient centred assessment of quality of life for patients with four common conditions. Qual Health Care 1999; 8: 22-29[Abstract].
13. EuroQol Group. EuroQol---a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208[CrossRef][Web of Science][Medline].
14. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded arthritis impact measurement scales health status questionnaire. Arthritis Rheum 1992; 35: 1-10[Web of Science][Medline].
15. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rhuematol 1982; 9: 789-793[Web of Science][Medline].
16. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376[Abstract/Free Full Text].
17. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805[Web of Science][Medline].
18. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985; 35: 185-188[Web of Science][Medline].
19. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. Health utilities index. Pharmacoeconomics 1995; 7: 490-502[Web of Science][Medline].
20. Fried BJ, Boers M, Baker PR. A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process. J Rheumatol 1993; 20: 548-551[Web of Science][Medline].
21. Bombardier C. Outcome assessments in the evaluation of treatment of spinal disorders. Spine 2000; 25: 3097-3099[CrossRef][Web of Science][Medline].
22. Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ 2001; 322: 1297-1300[Free Full Text].

(Accepted 9 January 2002)


© BMJ 2002

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Patient reported outcome measures in trials
Andrew Garratt
BMJ 2009 338: a2597. [Extract] [Full Text]

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review
Despina G Contopoulos-Ioannidis, Anastasia Karvouni, Ioanna Kouri, and John P A Ioannidis
BMJ 2009 338: a3006. [Abstract] [Full Text] [PDF]

Should NICE evaluate complementary and alternative medicine?
Linda Franck, Cyril Chantler, and Michael Dixon
BMJ 2007 334: 506. [Extract] [Full Text] [PDF]

Recommendations from quality of life scales are not simple
Michael E Hyland
BMJ 2002 325: 599. [Extract] [Full Text]

Quality of life measures soar
BMJ 2002 324: 0. [Full Text] [PDF]

This article has been cited by other articles:

  • Abresch, R. T., Carter, G. T., Han, J. J., McDonald, C. M. (2009). New Clinical End Points in Rehabilitation Medicine: Tools for Measuring Quality of Life. AM J HOSP PALLIAT CARE 26: 483-492 [Abstract]  
  • Risberg, M. A., Holm, I. (2009). The Long-term Effect of 2 Postoperative Rehabilitation Programs After Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Clinical Trial With 2 Years of Follow-Up. Am J Sports Med 37: 1958-1966 [Abstract] [Full text]  
  • Bottomley, A., Coens, C., Suciu, S., Santinami, M., Kruit, W., Testori, A., Marsden, J., Punt, C., Sales, F., Gore, M., MacKie, R., Kusic, Z., Dummer, R., Patel, P., Schadendorf, D., Spatz, A., Keilholz, U., Eggermont, A. (2009). Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. JCO 27: 2916-2923 [Abstract] [Full text]  
  • HUDSON, M., STEELE, R., LU, Y., THOMBS, B. D., PANOPALIS, P., BARON, M., for the Canadian Scleroderma Research Group, (2009). Clinical Correlates of Self-reported Physical Health Status in Systemic Sclerosis. The Journal of Rheumatology 36: 1226-1229 [Abstract] [Full text]  
  • Garratt, A. (2009). Patient reported outcome measures in trials. BMJ 338: a2597-a2597 [Full text]  
  • Contopoulos-Ioannidis, D. G, Karvouni, A., Kouri, I., Ioannidis, J. P A (2009). Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ 338: a3006-a3006 [Abstract] [Full text]  
  • Bleicken, B., Hahner, S., Loeffler, M., Ventz, M., Allolio, B., Quinkler, M. (2008). Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. Eur J Endocrinol 159: 811-817 [Abstract] [Full text]  
  • Strandberg, A. Y., Strandberg, T. E., Pitkala, K., Salomaa, V. V., Tilvis, R. S., Miettinen, T. A. (2008). The Effect of Smoking in Midlife on Health-Related Quality of Life in Old Age: A 26-Year Prospective Study. Arch Intern Med 168: 1968-1974 [Abstract] [Full text]  
  • Hambly, K., Griva, K. (2008). IKDC or KOOS? Which Measures Symptoms and Disabilities Most Important to Postoperative Articular Cartilage Repair Patients?. Am J Sports Med 36: 1695-1704 [Abstract] [Full text]  
  • VanBeek, M. J. (2008). Integrating Patient Preferences With Health Utilities: A Variation on Health-Related Quality of Life. Arch Dermatol 144: 1037-1041 [Full text]  
  • Zanon, F., Bacchiega, E., Rampin, L., Aggio, S., Baracca, E., Pastore, G., Marotta, T., Corbucci, G., Roncon, L., Rubello, D., Prinzen, F. W. (2008). Direct His bundle pacing preserves coronary perfusion compared with right ventricular apical pacing: a prospective, cross-over mid-term study. Europace 10: 580-587 [Abstract] [Full text]  
  • Magwood, G. S., Zapka, J., Jenkins, C. (2008). A Review of Systematic Reviews Evaluating Diabetes Interventions: Focus on Quality of Life and Disparities. The Diabetes Educator 34: 242-265 [Abstract] [Full text]  
  • Saarni, S I, Saarni, E S, Saarni, H (2008). Quality of life, work ability, and self employment: a population survey of entrepreneurs, farmers, and salary earners. Occup. Environ. Med. 65: 98-103 [Abstract] [Full text]  
  • Saarni, S. I., Joutsenniemi, K., Koskinen, S., Suvisaari, J., Pirkola, S., Sintonen, H., Poikolainen, K., LOnnqvist, J. (2008). Alcohol Consumption, Abstaining, Health Utility, and Quality of Life - A General Population Survey in Finland. Alcohol Alcohol 0: agn003v1-agn003 [Abstract] [Full text]  
  • Onishi, T., Nishikawa, K., Hasegawa, Y., Yamada, Y., Soga, N., Arima, K., Yamakado, K., Hoshina, A., Sugimura, Y. (2007). Assessment of Health-related Quality of Life after Radiofrequency Ablation or Laparoscopic Surgery for Small Renal Cell Carcinoma: a Prospective Study with Medical Outcomes Study 36-Item Health Survey (SF-36). Jpn J Clin Oncol 0: hym107v1-5 [Abstract] [Full text]  
  • Di Gallo, A., Felder-Puig, R., Topf, R. J. (2007). Quality of Life from Research and Clinical Perspectives: An Example from Paediatric Psycho-oncology. Clin Child Psychol Psychiatry 12: 599-610 [Abstract]  
  • Hjollund, N. H., Larsen, F. B., Andersen, J. H. (2007). Register-based follow-up of social benefits and other transfer payments: Accuracy and degree of completeness in a Danish interdepartmental administrative database compared with a population-based survey. Scand J Public Health 35: 497-502 [Abstract]  
  • Herrera, F. J., Wong, J., Chung, F. (2007). A Systematic Review of Postoperative Recovery Outcomes Measurements After Ambulatory Surgery. Anesth. Analg. 105: 63-69 [Abstract] [Full text]  
  • SAARNI, S. I., SUVISAARI, J., SINTONEN, H., PIRKOLA, S., KOSKINEN, S., AROMAA, A., LONNQVIST, J. (2007). Impact of psychiatric disorders on health-related quality of life: general population survey. Br. J. Psychiatry 190: 326-332 [Abstract] [Full text]  
  • Franck, L., Chantler, C., Dixon, M. (2007). Should NICE evaluate complementary and alternative medicine?. BMJ 334: 506-506 [Full text]  
  • Vetter, T. R. (2007). A Primer on Health-Related Quality of Life in Chronic Pain Medicine. Anesth. Analg. 104: 703-718 [Abstract] [Full text]  
  • Michalak, E. E., Yatham, L. N., Lam, R. W. (2007). Quality of Life in Bipolar Disorder: A Review of the Literature. Focus 5: 117-134 [Abstract] [Full text]  
  • Saigal, S., Stoskopf, B., Pinelli, J., Streiner, D., Hoult, L., Paneth, N., Goddeeris, J. (2006). Self-Perceived Health-Related Quality of Life of Former Extremely Low Birth Weight Infants at Young Adulthood. Pediatrics 118: 1140-1148 [Abstract] [Full text]  
  • Groenvold, M., Petersen, M. Aa., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., Fayers, P. M., de Graeff, A., Hammerlid, E., Kaasa, S., Sprangers, M. A. G., Bjorner, J. B. (2006). Letter to the Editor. Palliat Med 20: 59-61  
  • Segui-Gomez, M., MacKenzie, E. J. (2003). Measuring the Public Health Impact of Injuries. Epidemiol Rev 25: 3-19 [Full text]  
  • McKevitt, C, Redfern, J, La-Placa, V, Wolfe, C D. (2003). Defining and using quality of life: a survey of health care professionals. Clin Rehabil 17: 865-870 [Abstract]  
  • Hyland, M. E (2002). Recommendations from quality of life scales are not simple. BMJ 325: 599-599 [Full text]  

Rapid Responses:

Read all Rapid Responses

Physicians are critical of QOL
Vasiliy V Vlassov
bmj.com, 17 Jun 2002 [Full text]
QOL scale recommendations aren't that simple
Michael E Hyland
bmj.com, 2 Jul 2002 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ